Antineoplastons Therapy Can Switch Off Cancer Cells

How a Little-Known Therapy Called Antineoplastons Can “Switch Off Cancer Cells” Without Destroying Normal Cells

What if there were a safe, effective cure for cancer? One that’s…been proven effective in clinical trials…has many documented success stories…has been in use since 1967…comes with none of the harrowing side effects of chemotherapy and radiation…was featured in a high-profile, award-winning documentary…commands the interest of many of the world’s leading alternative practitioners and media superstars, including Dr. Mehmet Oz and including Oprah Winfrey?

The truth is, such a treatment does exist. It is being administered to select patients right now. If you or someone you love has reason to worry about cancer, this is information you must have.

A Startling Discovery

Stanislaw R. Burzynski, M.D., Ph.D., is an internationally recognized physician and scientist. He has devoted his entire career to cancer research, and for more than 40 years he has treated cancer patients from all over the world at his Houston, Texas clinic (called The Burzynski Clinic).

Dr. Burzynski is renowned known for discovering antineoplastons, substances in the body that naturally acts as “molecular switches” to turn off cancer cells without destroying normal cells.

Antineoplaston therapy may very well be the most effective gene-targeted cancer therapy the world has ever seen. Antineoplaston

What are Antineoplastons…and How Did Burzynski Discover Them?

Antineoplastons are peptides and amino acid derivatives contained in human blood and urine. According to Dr. Burzynski, they are also components of a “biochemical defense system” that controls cancer without destroying normal cells.

Dr. Burzynski first discovered antineoplastons in 1967. His discovery was monumental, because at that time researchers assumed they’d already identified and documented every substance in human blood and urine.

As Dr. Julian Whitaker stated in the award-winning 2010 documentary about Burzynski’s life and work (Burzynski, The Movie), “discovering something in the urine (and blood) at that time, that had never been discovered before—is like finding a whole bunch of new islands ten miles off the coast of Miami, it came as a big surprise.”

How Antineoplastons Evolved as a Cure for Cancer

At first, Dr. Burzynski wasn’t quite sure what his discovery meant or where it would lead. But he suspected these newly identified substances held great potential for science and medicine. His colleagues agreed, and Dr. Burzynski continued his research.

The next big breakthrough came rather quickly, as Dr. Burzynski tested sample after sample of human blood from a wide variety of donors that included various ethnic and age subgroups, both men and women, and individuals with various health conditions, including cancer. What Dr. Burzynski discovered shocked him: the peptides were either absent, or nearly so, in the blood of individuals with cancer.

Dr. Burzynski hypothesized that if he could extract antineoplastons from healthy donors and administer them to people with cancer, perhaps they would fight the disease. He was exactly right, and many patients benefited enormously from undergoing his treatments, even though these patients were among the most hopeless of all cancer cases.

Dr. Burzynski soon discovered, however, that the amount of blood needed to obtain a necessary amount of antineoplastons far exceeded the amount of blood reasonably available. He began extracting the needed substances from human urine, instead, since he could much more easily obtain large amounts of healthy human urine than blood.

By early 1980, however, Dr. Burzynski stopped extracting the peptides from urine and devised a state-of-the-art synthetic production process that totally eliminated the need for blood or urine. Today, Dr. Burzynski synthesizes the treatments in his massive 46,000 square foot manufacturing facility in Texas.

His antineoplaston treatments have helped countless people with hopeless, incurable cancer to regain their health and reclaim their lives.

How Do Antineoplastons Fight Cancer?

Antineoplastons are like molecular switches. They shut off life processes in abnormal cells and force them to die through apoptosis (programmed death of a cell). Fortunately, antineoplastons selectively target cancer cells and are completely harmless to healthy cells.

Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. The full medical records of various cancer survivors who have used these medicines instead of surgery, chemotherapy, or radiation are made available through the website of Burzynski, The Movie.

In addition, several systematic FDA-supervised clinical trials comparing antineoplastons to other available treatments have been published in peer-reviewed medical literature.

Big Medicine Vs. Dr. Burzynski

From 1977-1995, Dr. Burzynski was able to produce and administer his breakthrough treatment without FDA approval, because the state of Texas didn’t require physicians to adhere to this aspect of Federal law. Later, this situation changed, and when it did, it unleashed a treacherous 14-year battle waged by the FDA and Big Pharma against Dr. Burzynski and his patients.

The Texas Medical Board launched numerous investigations of Dr. Burzynski, relentlessly fighting their battle against him all the way to Texas Supreme Court. Burzynski, The Movie (which won the Humanitarian Vision Award at the New Port Beach Film Festival, 2010) tells the shocking story of that battle, supported b amazing first-person accounts of patients cured by Burzynski’s treatment.

Ironically, the amazing effectiveness of antineoplaston therapy is the very reason Burzynski has been so viciously attacked. His successful cancer treatments pose much too great a threat to the profit margins of the highly lucrative cancer industry. If antineoplastons are approved (which could happen after completion of Phase III clinical trials), it will mark the first time in history that a single scientist—not a pharmaceutical company—will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough.

Burzynski himself would hold an exclusive right to manufacture and sell antineoplastons on the open market. This would the pharmaceutical industry completely out of the profit loop for most effective gene-targeted cancer treatment the world has ever seen.

That’s why it’s no wonder the Medical Machine has done everything in its power to stop Burzynski…or to falsely claim his patents. The New York Times calls Dr. Burzynski “a stoic victim of patent fraud, government harassment and scientific sabotage.” The widely popular Dr. Joseph Mercola says that Burzynski’s story “makes the ‘Watergate scandal’ look like a kindergarten pottery class.” And Variety calls Burzynski’s story “a dramatic expose of the FDA and its incestuous relationship with Big Pharma as it seeks to first discredit, then co-opt Burzynski’s discovery.”

Obtaining Antineoplaston Therapy

Continuous research on antineoplastons is conducted and supervised by a team of experienced and committed scientists at the Burzynski Clinic and the Burzynski Research Institute.

Antineoplaston therapy is not, however, approved by the FDA for the treatment of any disease. It is offered only as an experimental therapy at the Burzynski Clinic, currently available only to those enrolled in clinical trials.

To find out more about the eligibility criteria for enrollment in clinical trials, you should contact the Burzynski Clinic directly.

Warning: A non-numeric value encountered in /home/thinkout/public_html/ on line 352